- Acumen Powered by Robins Kaplan LLP®
- Affirmative Recovery
- American Indian Law and Policy
- Antitrust and Trade Regulation
- Appellate Advocacy and Guidance
- Business Litigation
- Civil Rights and Police Misconduct
- Class Action Litigation
- Commercial/Project Finance and Real Estate
- Corporate Governance and Special Situations
- Corporate Restructuring and Bankruptcy
- Domestic and International Arbitration
- Entertainment and Media Litigation
- Health Care Litigation
- Insurance and Catastrophic Loss
- Intellectual Property and Technology Litigation
- Mass Tort Attorneys
- Medical Malpractice Attorneys
- Personal Injury Attorneys
- Telecommunications Litigation and Arbitration
- Wealth Planning, Administration, and Fiduciary Disputes
Acumen Powered by Robins Kaplan LLP®
Ediscovery, Applied Science and Economics, and Litigation Support Solutions
-
September 10, 2024Robins Kaplan Ranks Among Top Firms In 2024 American Lawyer Mid-Level Associates Survey
-
September 9, 2024Federal Judge Orders Transformative Reforms at West LA VA Campus in Major Victory for Disabled Veterans
-
September 9, 2024Robins Kaplan Partners Named to 2025 Lawdragon 500 Leading Litigators in America Guide
-
September 27, 2024Minnesota’s Largest Patent Jury Verdict: The Inside Story
-
October 9, 2024Perception vs. Reality in Trust and Estate Matters:
-
October 20, 2024License Agreement Disputes:
-
September 2024Q&A with Alan Harter, Founder of Pactolus Private Wealth Management
-
August 2024Recruiting & Retaining Diverse Attorneys: Building an Inclusive Legal Profession
-
August 22, 2024Prior Art Takeaways From Fed. Circ. Public Disclosure Ruling
-
September 16, 2022Uber Company Systems Compromised by Widespread Cyber Hack
-
September 15, 2022US Averts Rail Workers Strike With Last-Minute Tentative Deal
-
September 14, 2022Hotter-Than-Expected August Inflation Prompts Massive Wall Street Selloff
Find additional firm contact information for press inquiries.
Find resources to help navigate legal and business complexities.
Read our attorneys' take on the latest news and trends in the legal and business industries.
Generic Launches
Abbreviated New Drug Applications and 505(b)(2) Applications
Second Quarter
This chart tracks the date, drug, reference-listed company, applicant, and indications of publicly available drug launches resulting from Abbreviated New Drug Applications and 505(b)(2) Applications.
Reference Listed Drug | ANDA Holder | Generic Drug Name | ANDA Applicant(s) |
Indication | Launch Date |
---|---|---|---|---|---|
Astelin | MEDA | azelastine | Aurobindo | Used for the relief of the symptoms of seasonal allergic rhinitis in patients 6 years of age and older and perennial allergic rhinitis in patients 6 years of age and older | 4/6/2021 |
Kuvan | Biomarin | saproterin | Dr. Reddy's | Used to lower blood Phe levels in adults and children over one month of age with a certain type of Phenylketonuria (PKU) | 4/7/2021 |
Urocit-K | Mission | potassium citrate | Hetero/Camber | Used for preventing certain types of kidney stones | 4/8/2021 |
Librax | Bausch & Lomb | chlordiazepoxide / clidinium | Xiromed | Used to treat emotional distress caused by having a stomach disorder (such as an ulcer, irritable bowel syndrome, or intestinal infection) | 4/9/2021 |
Quelicin | Hospira | succinylcholine chloride | Nexus | Used as an adjunct to general anesthesia, to facilitate tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation | 4/16/2021 |
Sabril | Lundbeck | vigabatrin | Hetero/Camber | Used to treat Refractory Complex Partial Seizures and Infantile Spasms | 4/20/2021 |
Bloxiverz | Exela | neostigamine | Hetero/Camber | Used to reverse the effects of non-depolarizing neuromuscular blocking agents (NMBAs) after surgery | 4/22/2021 |
Canasa | AbbVie | mesalamine | Teva | Used to treat mildly to moderately active ulcerative proctitis | 4/23/2021 |
Absorica | Sun | isotretinoin | Teva | Used to manage of severe recalcitrant nodular acne in patients 12 years of age and older | 4/29/2021 |
Enablex | APIL | darifenacin | Xiromed | Used to treat overactive bladder with symptoms of urge urinary incontinence, urgency and frequency | 5/5/2021 |
Precedex | Pfizer | dexmedetomidine | Hikma | Used for sedation of non-intubated patients prior to and/or during surgical and other procedures | 5/6/2021 |
Taxotere | Sanofi | docetaxel | Hikma | Microtubule inhibitor indicated for the treatment of breast cancer, non-small cell lung cancer, hormone refractory prostate cancer, gastric adenocarcinoma, and squamous cell carcinoma of the head and neck cancer | 5/7/2021 |
Invanz | Merck | ertapenem | Dr. Reddy's | Used to treat adult patients and pediatric patients (3 months of age and older) with the moderate to severe infections caused by susceptible isolates of the designated microorganisms in complicated intra-abdominal infections, complicated skin and skin structure infections, including diabetic foot infections without osteomyelitis, community acquired pneumonia, complicated urinary tract infections including pyelonephritis and acute pelvic infections including postpartum endomyometritis, septic abortion and post surgical gynecologic infections | 5/12/2021 |
Thiola | Mission | tiopronin | Teva | Used, in combination with high fluid intake, alkali, and diet modification, for the prevention of cysteine (kidney) stone formation in adults and pediatric patients 9 years of age and older with severe homozygous cystinuria, who are not responsive to these measures alone | 5/17/2021 |
Miacalcin | Mylan | calcitonin salmon | Leucadia/Custopharm | Used for the early treatment of hypercalcemic emergencies when a rapid decrease in serum calcium is required | 5/17/2021 |
Torisel | Pfizer | temsirolimus | Fresenius Kabi | Used to treat advanced renal cell carcinoma | 5/21/2021 |
Strattera | Eli Lilly | atamoxetine | Hetero/Camber | Used to treat attention-deficit/hyperactivity disorder (ADHD) | 5/24/2021 |
Vigamox | Novartis | moxifloxacin | Upsher-Smith | Used to treat bacterial conjunctivitis caused by susceptible strains of the organisms | 5/27/2021 |
Banzel | Eisai | rufinamide | Hetero/Camber | Used for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults | 6/1/2021 |
Banzel | Eisai | rufinamide | Glenmark | Used for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults | 6/1/2021 |
Delestrogen | Sandoz | estradiol valerate | Hikma | Used for the treatment of vasomotor symptoms associated with menopause; (ii) in the management of hormonal imbalances due to castration or primary ovarian failure; and (iii) in the treatment of androgen-dependent carcinoma of the prostate. | 6/2/2021 |
Brovana | Sunovion | arformoterol | Lupin | Used for the long-term, twice daily (morning and evening) maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. | 6/3/2021 |
Kaletra | AbbVie | lopinavir / ritonavir | Hetero/Camber | Used with other HIV medications to help control HIV infection | 6/7/2021 |
Prevacid | Takeda | lansoprazole | Hetero/Camber | Used to treat high levels of stomach acid; active ulcers of the stomach and small intestine, Gastroesophageal Reflux Disease (GERD), and Zollinger-Ellison Syndrome | 6/15/2021 |
Soolantra | Galderma | ivermectin | Teva | Used to treat inflammatory lesions of rosacea. | 6/16/2021 |
Truvada | Gilead | emtricitabine / tenofovir | Apotex | Used, in combination with other antiretroviral agents for the treatment of HIV-1 infection | 6/18/2021 |
Vascepa | Amarin | icosapent | Dr. Reddy's | Used as an adjunct to diet to reduce triglyceride levels in adult patients with severe (≥500 mg/dL) hypertriglyceridemia | 6/22/2021 |
Perforomist | Mylan | formoterol | Teva | Used with a nebulizer to control the symptoms of COPD in adults, including those with chronic bronchitis and/or emphysema, the two main types of the disease | 6/22/2021 |
Banzel | Eisai | rufinamide | Hikma | Used for adjunctive treatment of seizures associated with Lennox-Gastaut Syndrome in pediatric patients 1 year of age and older and in adults | 6/24/2021 |
Truvada | Gilead | emtricitabine / tenofovir | Lupin | Used, in combination with other antiretroviral agents for the treatment of HIV-1 infection | 6/25/2021 |
Absorica | Sun | isotretinoin | Upsher-Smith/Sawai | Used to manage severe recalcitrant nodular acne in patients 12 years of age and older | 6/25/2021 |
GENERICally Speaking Summer 2021
GENERICally Speaking Summer 2021
Summer 2021 Related Publications
Second Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
June 25, 2024
Amarin Pharma, Inc. v. Hikma Pharms. USA Inc.
GENERICally Speaking Hatch Waxman Bulletin
June 10, 2024
Teva Branded Pharm. Products R&D, Inc. v. Amneal Pharms. of NY, LLC
GENERICally Speaking Hatch Waxman Bulletin
April 30, 2024
Pharmacyclics LLC v. Alvogen Pine Brook LLC
GENERICally Speaking Hatch Waxman Bulletin
First Quarter
GENERICally Speaking: A Hatch-Waxman Litigation Bulletin
Oren Langer, Christopher Pinahs, Emily Tremblay, and Christine May
Related News
October 14, 2022
September 9, 2022
Back to Top
Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins Kaplan LLP. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.